close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Eli Lilly (NY:LLY)

906.86 +10.33 (+1.15%)
Official Closing Price Updated: 7:00 PM EST, Nov 4, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Eli Lilly

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Eli Lilly And Novo Nordisk Ignite Bullish Retail Frenzy Ahead Of TrumpRx Deals To Slash Prices For Weight-Loss Drugs
Via Stocktwits
Viatris (VTRS) Q3 Earnings Report Preview: What To Look For
Medication company Viatris (NASDAQ:VTRS) will be reporting earnings this Thursday before market open. Here’s what investors should know. 
Via StockStory
Topics Artificial Intelligence
Amphastar Pharmaceuticals (AMPH) To Report Earnings Tomorrow: Here Is What To Expect
Via StockStory
Billionaire Stanley Druckenmiller Dropped Nvidia and Palantir Stock and Is Piling into 2 Stocks Set to Win in One of the Decade's Hottest Growth Markets.
It's a great idea to watch the latest moves of this expert investor. 
Via The Motley Fool
Topics Artificial Intelligence
Novo Nordisk Q3 Preview: Analysts See Profit Drop As Obesity Market Cools, Pfizer Tensions Rise
Via Stocktwits
AI Unleashes a New Era in Cell and Gene Therapy: A Quarter Century Update Reveals Transformative Potential
The burgeoning fields of cell and gene therapy (CGT) are on the cusp of a profound revolution, driven by the relentless advancements in artificial intelligence. This transformative impact was a central... 
Via TokenRing AI
Topics Artificial Intelligence
Eli Lilly Posts Stellar Q3: Long-Term Upside Is Well in Play
Via MarketBeat
Eli Lilly, Novo Nordisk Stocks Rise on Reported $149 Obesity Drug Deal with White House
Eli Lilly and Company (NYSE:LLY) shares are trading slightly lower on Tuesday after its previous gains following reports indicating the company is close to finalizing a White House agreement to provide... 
Via Benzinga
Is Eli Lilly a Millionaire Maker?
Eli Lilly has a leading position in a hot new drug category, but there's one notable problem to consider. 
Via The Motley Fool
Topics Intellectual Property
Are Wall Street Analysts Predicting Eli Lilly Stock Will Climb or Sink?
While the pharma giant Eli Lilly has lagged behind the broader market over the past year, it has outpaced the health care space, and analysts remain strongly bullish on the stock’s prospects. 
Via Barchart.com
Elanco (ELAN) To Report Earnings Tomorrow: Here Is What To Expect
Animal health company Elanco (NYSE:ELAN) will be reporting earnings this Wednesday before market hours. Here’s what investors should know. 
Via StockStory
Topics Artificial Intelligence
Earnings To Watch: Jazz Pharmaceuticals (JAZZ) Reports Q3 Results Tomorrow
Biopharma company Jazz Pharmaceuticals (NASDAQ:JAZZ) will be reporting earnings this Wednesday afternoon. Here’s what to expect. 
Via StockStory
Topics Artificial Intelligence
What To Expect From Royalty Pharma’s (RPRX) Q3 Earnings
Healthcare royalties company Royalty Pharma (NASDAQ:RPRX) will be reporting earnings this Wednesday before the bell. Here’s what to look for. 
Via StockStory
Topics Artificial Intelligence
Hims & Hers Health (HIMS) Surges After Hours on Robust Q3 and Renewed Novo Nordisk (NVO) Wegovy Talks
Hims & Hers Health (NYSE: HIMS) became a significant after-hours mover on Monday, November 3, 2025, following the release of its third-quarter 2025 financial results and the pivotal announcement of... 
Via MarketMinute
Topics Artificial Intelligence Economy
Stay informed with the top movers within the S&P500 index on Monday.
Uncover the latest developments among S&P500 stocks in today's session. Stay tuned to the S&P500 index's top gainers and losers on Monday. 
Via Chartmill
What's Up With The Rise In Eli Lilly Stock Today?
Eli Lilly shares are trading higher on Monday. The pharmaceutical giant announced a significant European manufacturing expansion. 
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
 
Via Benzinga
ELI LILLY & CO (NYSE:LLY): A Dividend Growth Stock with Strong Profitability
Discover Eli Lilly (LLY), a dividend stock with a 10+ year payment history, 15.59% average growth, strong profitability, and solid financial health for reliable income. 
Via Chartmill
2 Healthcare Stocks for Individual Investors With a 30-Year Time Horizon
The healthcare industry is chock-full of opportunities for long-term investors. 
Via The Motley Fool
Topics Government World Trade
2 Beaten-Down Stocks That Could Be About to Rally
It would be best to get in before the rest of the market pounces on these opportunities. 
Via The Motley Fool
Prediction: The Next Eli Lilly Might Already Be Trading Under $50
Biotech Viking Therapeutics has gained prominence over the past two years, but it could have plenty of upside left. 
Via The Motley Fool
What To Expect From Zoetis’s (ZTS) Q3 Earnings
Animal health company Zoetis (NYSE:ZTS) will be reporting results this Tuesday morning. Here’s what to look for. 
Via StockStory
Topics Artificial Intelligence
Corcept Earnings: What To Look For From CORT
Biopharma company Corcept Therapeutics (NASDAQ:CORT) will be reporting results this Tuesday after market close. Here’s what to look for. 
Via StockStory
Topics Artificial Intelligence
Pfizer (PFE) Q3 Earnings: What To Expect
Global pharmaceutical company Pfizer (NYSE:PFE) will be announcing earnings results this Tuesday before market open. Here’s what you need to know. 
Via StockStory
Topics Artificial Intelligence
Supernus Pharmaceuticals (SUPN) Reports Q3: Everything You Need To Know Ahead Of Earnings
Specialty pharmaceutical company Supernus Pharmaceuticals (NASDAQ:SUPN) will be reporting earnings this Tuesday after market hours. Here’s what you need to know. 
Via StockStory
Topics Artificial Intelligence
Rethinking Your Portfolio: The Stocks That Could Outperform for Years
Now is a great time to be shopping for stocks that can anchor your portfolio. 
Via The Motley Fool
Topics Bonds Retirement
Should You Buy Viking Therapeutics Before Nov. 5?
Viking's stock surged in one trading session after a positive clinical trial report last year. 
Via The Motley Fool
Should You Buy the Vanguard S&P 500 ETF With the Stock Market at All-Time Highs? History Offers a Clear Answer
Powerful themes like artificial intelligence (AI) continue to drive the S&P 500 to new highs. 
Via The Motley Fool
Topics Artificial Intelligence ETFs Economy
AI Unleashes a New Era: Biopharma’s Accelerated Revolution and the Rise of TechBio
The biopharmaceutical industry is undergoing an immediate and profound transformation, as Artificial Intelligence (AI) rapidly compresses timelines, drastically reduces costs, and significantly... 
Via TokenRing AI
Topics Animal Testing Artificial Intelligence Economy
S&P 500 Giants JPMorgan, Eli Lilly Lead Five Stocks Near Buy Points
Four are already actionable, with the holdout just below a possible breakout. 
Via Investor's Business Daily
Topics Stocks
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today